Ginjaleling is a medicinal product based on components of plant origin intended for the treatment of nephroluritiasis. It has a pronounced antispasmodic and weak diuretic action, promotes the removal of small stones from the urinary tract.
Release form and composition
Make Ginjaleling capsules of 500 mg each, in blisters of 10 capsules or in polymeric bottles of 75 pieces each.
1 capsule contains a thick aqueous extract from a mixture of the following plant components:
- The leaves of the strobilant curly;
- The leaves of the orthophysophon staminate;
- Rhizomes imperata cylindrical;
- Phyllanthus leaves Niruri.
Additional components of the drug are: colloidal silicon dioxide, talc, corn starch, magnesium stearate, nipazol, nipagin.
Indications for use
According to the instructions, Ginjaleling indicated for use in urolithiasis. The drug is prescribed for the purpose of removing from the upper urinary tract and renal pelvis of small stones, the size of which does not exceed 0.3-0.4 cm.
In the complex treatment, Ginjaleling is prescribed to release the ureter from the remains of stones left after lithotripsy.
According to the instructions, Ginjaleling has no contraindications to the use. The exception is patients who have hypersensitivity to the active or auxiliary components of the drug.
Dosing and Administration
Ginjaleling appoint 2 capsules three times a day, washed down with a glass of water at room temperature. With the preventive purpose, take 1 capsule of the drug three times a day. The duration of therapy ranges from three months to six months.
If there is a need for more prolonged use of Ginjaleling, it is recommended to consult with your doctor.
The use of Ginjaleling is mainly positively tolerated by patients, side effects rarely occur. The most common allergic reactions due to hypersensitivity to any of the active or auxiliary components of the drug.
For the period of Ginjaleling treatment, patients are recommended to increase the daily volume of fluid consumed.
Data overdose of the drug is not provided.
The use of Ginjaleling during pregnancy and breastfeeding is not recommended, except in situations where the potential benefit to the mother outweighs the possible risks to the fetus / child.
During drug therapy, control of potentially dangerous mechanisms requiring high concentration of attention is not prohibited.
Ginjaleling has no structural analogs today.
Terms and conditions of storage
According to the instructions, Ginjaleling should be kept out of the reach of children, protected from moisture and direct sunlight, at a temperature of 10-30 degrees. The shelf life of the drug is 2 years.